Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ufuk Gunduz

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Expert Review of Anticancer Therapy|May 1, 2016
Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticlesGozde Unsoy, Ufuk Gunduz
Current Drug Targets|April 2, 2016
Smart Drug Delivery Systems in Cancer TherapyGozde Unsoy, Ufuk Gunduz
International Journal of Pharmaceutics|November 6, 2016
Changes in apoptosis-related gene expression and cytokine release in breast cancer cells treated with CpG-loaded magnetic PAMAM nanoparticlesNegar Taghavi Pourianazar, Ufuk Gunduz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 23, 2016
CpG oligodeoxynucleotide-loaded PAMAM dendrimer-coated magnetic nanoparticles promote apoptosis in breast cancer cellsNegar Taghavi Pourianazar, Ufuk Gunduz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2014
Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapyRouhollah Khodadust, Gozde Unsoy, Ufuk Gunduz
Hematology (Amsterdam, Netherlands)|September 14, 2007
Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cellsYusuf Baran, Ali Ugur Ural, Ufuk Gunduz
Journal of Cancer Research and Clinical Oncology|August 12, 2011
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulationYusuf Baran, Jacek Bielawski, Ufuk Gunduz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2014
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological featuresAhu Izgi, Armagan Gunal, Serap Yalcin, et al.
Journal of Drug Targeting|July 23, 2005
Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugateAsli Muvaffak, Ismet Gurhan, Ufuk Gunduz, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 12, 2020
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug DeliveryMaryam Parsian, Pelin Mutlu, Serap Yalcin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Expert Review of Anticancer Therapy|May 1, 2016
Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticlesGozde Unsoy, Ufuk Gunduz
Current Drug Targets|April 2, 2016
Smart Drug Delivery Systems in Cancer TherapyGozde Unsoy, Ufuk Gunduz
International Journal of Pharmaceutics|November 6, 2016
Changes in apoptosis-related gene expression and cytokine release in breast cancer cells treated with CpG-loaded magnetic PAMAM nanoparticlesNegar Taghavi Pourianazar, Ufuk Gunduz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 23, 2016
CpG oligodeoxynucleotide-loaded PAMAM dendrimer-coated magnetic nanoparticles promote apoptosis in breast cancer cellsNegar Taghavi Pourianazar, Ufuk Gunduz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2014
Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapyRouhollah Khodadust, Gozde Unsoy, Ufuk Gunduz
Hematology (Amsterdam, Netherlands)|September 14, 2007
Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cellsYusuf Baran, Ali Ugur Ural, Ufuk Gunduz
Journal of Cancer Research and Clinical Oncology|August 12, 2011
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulationYusuf Baran, Jacek Bielawski, Ufuk Gunduz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2014
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological featuresAhu Izgi, Armagan Gunal, Serap Yalcin, et al.
Journal of Drug Targeting|July 23, 2005
Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugateAsli Muvaffak, Ismet Gurhan, Ufuk Gunduz, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 12, 2020
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug DeliveryMaryam Parsian, Pelin Mutlu, Serap Yalcin, et al.
Pageof 4